 Second and Third Quarter 10-Q Filings Bring Vivos Currenton SEC Filings for Nasdaq Stock Market Purposes Management to Host Conference Call Today at 5:00 pm ET LITTLETON, Colo., Dec. 20, 2022 GLOBE NEWSWIRE Vivos Therapeutics, Inc. Vivos or the Company NASDAQ: VVOS, a medical technology company focused on developing innovative treatments for patients suffering ... The post Vivos Therapeutics Reports Second and Third Quarter 2022 Financial Results and Provides Operational Update appea... 